Invitrogen™ Human EPM2A Synthetic Peptide

Ref.: BL-RE-175537Manufacturer ref.: PEP-1478 50 μg
€149.00 excl. VAT

EPM2A Synthetic Peptide, PEP-1478, from Invitrogen.

Gene ID (Enter)
7957
Species
Human
Purification method
Purified
Accession number
B3EWF7
Common name
Human EPM2A
Brand
Invitrogen

EPM2A Synthetic Peptide, PEP-1478, from Invitrogen.

EPM2A Synthetic Peptide, PEP-1478, from Invitrogen.

The Epilepsy, progressive myoclonus type 2A protein (EPM2A) is a dual-specificity phosphatase that associates with polyribosomes. Mutations in this gene have been associated with myoclonic epilepsy of Lafora. EPM2A interacts with a number of proteins known to be involved in glycogen metabolism and has been shown to have robust phosphatase activity against a phosphorylated complex carbohydrate, suggesting that EPM2A may be involved in the regulation of glycogen metabolism.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15235389
Specifications
Gene ID (Enter)7957
SpeciesHuman
Purification methodPurified
Accession numberB3EWF7
Common nameHuman EPM2A
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)EPM2A
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1478
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.